IK Partners to invest in BIOBank alongside Management and historical shareholders Verto Growth and Capital Croissance

Press Release Wednesday, 29 May 2024

IK Partners (“IK”) is pleased to announce that the IK Small Cap III (“IK SC III”) Fund has signed an agreement to invest in BIOBank (“the Company”), a leading manufacturer and distributor of bone allografts for orthopaedic, spine, dental and cranio-maxillofacial (“CMF”) surgery. IK is acquiring a majority stake from Verto Growth (“Verto”), Capital Croissance and the management team, who will all be reinvesting. Financial terms of the transaction are not disclosed.